Asset profile
SAR448272 · Nurix Therapeutics (NRIX) Company NRIX Nurix Therapeutics Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery plat…
On the calendar Nothing scheduled in this window.
Readiness checklist Public facts only. We never publish an approval probability.
Updated Nov 3, 2026
Primary endpoint met Unknown
Overall survival significant or trending Unknown
US / Western patient share Unknown
Advisory committee scheduled Favourable
No advisory committee announced
PDUFA date extended Unknown
Manufacturing inspection record Unknown
No public inspection record
Company language signals (label discussions) Unknown
Same-class precedent Unknown
Related companies Each relationship is backed by the filing that stated it.
Sanofi S.A. Not US-listed Partner
Verify every date against the linked primary source. Informational only. Not investment advice. SimianX is not affiliated with the FDA or the SEC.
More from Nurix Therapeutics Other drugs and candidates from the same company tracked in this sector.